Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry—Defining the “Goods” at Stake-Reference-Cited by-同舟云学术

Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry—Defining the “Goods” at Stake

Published:2017-07-18 Issue:3 Volume:14 Page:401-410
ISSN:1176-7529
Container-title:Journal of Bioethical Inquiry
language:en
Short-container-title:Bioethical Inquiry

Author:

Ghinea Narcyz^ORCID,Little Miles,Lipworth Wendy

Funder

National Health and Medical Research Council (AU)

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Health(social science)

Link

http://link.springer.com/article/10.1007/s11673-017-9800-2/fulltext.html

Reference38 articles.

1. Booth, C.M., G. Dranitsaris, M.C. Gainford, et al. 2007. External influences and priority-setting for anti-cancer agents: A case study of media coverage in adjuvant trastuzumab for breast cancer. BMC Cancer 7(1): 110.

2. Conti, R.M., and M.B. Rosenthal. 2016. Pharmaceutical policy reform—Balancing affordability with incentives for innovation. New England Journal of Medicine 374(8): 703–706.

3. Daniel, H. 2016. Stemming the escalating cost of prescription drugs: A position paper of the American College of Physicians. Annals of Internal Medicine 165: 50–52.

4. Deloitte Access Economics. 2013. Access to cancer medicines in Australia. http://medicinesaustralia.com.au/files/2013/07/Access-to-oncology-medicines-1707-FINALV3.pdf . Accessed September 21, 2016.

5. Doglin, E. 2010. Big pharma moves from “blockbusters” to “niche busters.” Nature Medicine 16: 837.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological and ethical comparisons of lung cancer medicine accessibility in Australia and New Zealand;Journal of Medical Ethics;2024-08-28

2. Analysis of cancer drug prices: a narrative review of literature;Journal of Pharmaceutical Health Services Research;2022-08-09

3. Bizarre Bioethics;2022

4. Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature;International Journal of Health Policy and Management;2021-09-22

5. Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity?;Journal of Bioethical Inquiry;2020-02-14